Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simultaneous evaluation of EGFR, ALK, and PD-L1 in lung adenocarcinomas: the largest single-center experience from southern Brazil.

Genetics and molecular biology·2026
Same author

NeuroSAFE-guided robot-assisted radical prostatectomy versus standard RARP: systematic review and meta-analysis of comparative studies.

Journal of robotic surgery·2026
Same author

Role of Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer: Should It be Done?

The Urologic clinics of North America·2026
Same author

<sup>68</sup>Ga-PSMA-11 PET/CT for Initial Staging of Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Predicts Overall Survival: An IAEA Multicenter Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

<sup>68</sup>Ga-PSMA-11 in Staging of Unfavorable Intermediate- and High-Risk Prostate Cancer Reduces Indication for Noncurative Prostatectomy: A Prospective, Multicenter, IAEA Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.

The New England journal of medicine·2025

Related Experiment Video

Updated: Jun 25, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

[Primary adrenal leiomyosarcoma].

Flávio D Saavedra Tomasich1, Murilo de Almeida Luz, Massakazu Kato

  • 1Serviço de Cirurgia Abdominal, Hospital Erasto Gaertner, Liga Paranaense de Combate ao Câncer.

Arquivos Brasileiros De Endocrinologia E Metabologia
|February 7, 2009
PubMed
Summary
This summary is machine-generated.

Adrenal gland leiomyosarcoma is a rare, aggressive soft tissue sarcoma. Surgical removal is the primary treatment, but the disease often recurs, highlighting the need for further research.

More Related Videos

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Related Experiment Videos

Last Updated: Jun 25, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Area of Science:

  • Oncology
  • Pathology

Background:

  • Adrenal gland leiomyosarcoma is an exceptionally rare malignancy.
  • Associated with human immunodeficiency virus (HIV) and Epstein-Barr virus infections, though incidence remains low.
  • Originates from the central adrenal vein or its tributaries.

Observation:

  • A case report of a 48-year-old woman diagnosed with adrenal leiomyosarcoma via imaging.
  • The patient underwent surgical resection (adrenalectomy) of the adrenal mass.
  • Histopathology and immunohistochemistry confirmed primary adrenal leiomyosarcoma.

Findings:

  • The patient experienced disease recurrence 53 months post-adrenalectomy, leading to death.
  • Adrenal leiomyosarcoma exhibits aggressive behavior, consistent with other soft tissue sarcomas.
  • Adrenalectomy is the principal treatment modality.

Implications:

  • Despite rarity, adrenal leiomyosarcoma has a poor prognosis and aggressive nature.
  • Current treatment guidelines recommend surgery as the primary intervention.
  • Chemotherapy and radiotherapy are reserved for metastatic, bulky, or inoperable cases.